Protocol W with Dr. Raj Maturi
Jun 15, 2021•12 min•Ep. 23
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
We knew that anti-VEGF therapy favorably affected the natural history of moderate or severe nonproliferation retinopathy. As a result of DRCR network Protocol W, we now know that careful observation with treatment of complications as they develop produces visual acuity results at 2 years similar to prophylactic therapy.
For the best experience, listen in Metacast app for iOS or Android